We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Microbleeds a Marker for Stroke Complications

By HospiMedica staff writers
Posted on 11 Mar 2002
A study has found that patients with previous microscopic bleeding in the brain are much more likely to develop cerebral bleeding (CB) after stroke, compared to patients without microbleeds. More...
Conducted by French researchers, the study was published in the March 2002 issue of Stroke.

The researchers used a new imaging technique called T2-weighted gradient-echo magnetic resonance imaging (MRI) to detect the microbleeds. This technique is more sensitive that conventional MRI, which can fail to detect CB at an early stage of stroke. In the study, early CB was diagnosed in 26 of 100 stroke patients, aged 19-83. Eighteen were diagnosed at the acute stage and eight within the first week. The researchers found that the patients with a history of microbleeds were seven times more likely than others to develop CB after stroke. They say the use of microbleeds as a marker for serious stroke complications may help doctors identify patients who need to be treated more cautiously.

Old microbleeds can indicate that small blood vessels are diseased, which can be worsened by hypertension, diabetes, and the chronic use of drugs to prevent clots. "I urge practitioners to carefully manage patients with diabetes and hypertension because they could be at increased risk of microbleeds and for cerebral bleeding,” says Norbert Nighoghossian, M.D., professor of neurology at the Hospital Neurologique in Lyon (France) and lead author of the study.


Related Links:
Stroke

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammo DR Retrofit Solution
DR Retrofit Mammography
Radiation Safety Barrier
RayShield Intensi-Barrier
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.